Trademark: 79293599
Status Date
Tuesday, February 22, 2022
Registration Number
6648758
Registration Date
Tuesday, February 22, 2022
Filing Date
Wednesday, July 8, 2020
Published for Opposition
Tuesday, December 7, 2021
5 Adjuvants for medical purposes; cells for medical use; biological cell preparations for the treatment of diseases and disorders, namely, ophthalmic, central nervous system, respiratory, cardiovascular, liver, kidney, pancreatic, oncological, urological, and peripheral artery related diseases and disorders, as well as type 1 and type 2 diabetes, gynecological disease and stroke; pharmaceutical preparations for the prevention or treatment of ophthalmic, central nervous system, respiratory, cardiovascular, liver, kidney, pancreatic, oncological, urological, and peripheral artery related diseases and disorders, as well as type 1 and type 2 diabetes, gynecological disease and stroke
10 Medical apparatus and instruments, namely, instruments and syringes for the regeneration of stem cells for medical purposes, excluding any electrical pulsing technology instruments; Medical apparatus and instruments, namely, instruments and syringes for medical use for administration or transplanting of stem cells or cells differentiated from iPS cells, excluding any electrical pulsing technology instruments; prosthetic tissues for parietal, visceral and vascular use; Medical apparatus and instruments, namely, syringes for medical purposes for injections for administration or transplanting of stem cells or cells differentiated from iPS cells, excluding any electrical pulsing technology instruments; Medical apparatus and instruments, namely, syringes for medical purposes for injections for the regeneration of stem cells for medical purposes, excluding any electrical pulsing technology instruments; eye testing machines and apparatus; Medical apparatus and instruments, namely, instruments and syringes for treating of ophthalmic, central nervous system, respiratory, cardiovascular, liver, kidney, pancreatic, oncological, and gynecological diseases and disorders, as well as type 1 and type 2 diabetes and stroke, and for administration or transplanting of stem cells or cells differentiated from iPS cells, excluding any electrical pulsing technology instruments; and Medical apparatus and instruments, namely, instruments and syringes for treating of ophthalmic, central nervous system, respiratory, cardiovascular, liver, kidney, pancreatic, oncological, and gynecological diseases and disorders, as well as type 1 and type 2 diabetes and stroke, and for the regeneration of stem cells for medical purposes, excluding any electrical pulsing technology instruments
42 Scientific and medical research and development in the field of cells; research and development of pharmaceuticals and medical apparatus and instruments for others; research and development services relating to medicines; testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs
The mark consists of overall circular design comprised of three nested crescent shapes.
Color is not claimed as a feature of the mark.
May 14, 2023
Change Of Name/Address Rec'd From Ib
Aug 16, 2022
Final Decision Transaction Processed By Ib
Jul 27, 2022
Final Disposition Notice Sent To Ib
Jul 27, 2022
Final Disposition Processed
May 22, 2022
Final Disposition Notice Created, To Be Sent To Ib
Feb 22, 2022
Registered-Principal Register
Dec 13, 2021
Notification Processed By Ib
Dec 7, 2021
Official Gazette Publication Confirmation E-Mailed
Dec 7, 2021
Published For Opposition
Nov 17, 2021
Notification Of Possible Opposition Sent To Ib
Nov 17, 2021
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Nov 17, 2021
Notification Of Notice Of Publication E-Mailed
Nov 3, 2021
Approved For Pub - Principal Register
Nov 3, 2021
Examiner's Amendment Entered
Nov 3, 2021
Notification Of Examiners Amendment E-Mailed
Nov 3, 2021
Examiners Amendment E-Mailed
Nov 3, 2021
Examiners Amendment -Written
May 13, 2021
Notification Of Non-Final Action E-Mailed
May 13, 2021
Non-Final Action E-Mailed
May 13, 2021
Non-Final Action Written
Apr 8, 2021
Teas/Email Correspondence Entered
Apr 7, 2021
Correspondence Received In Law Office
Apr 7, 2021
Teas Response To Office Action Received
Apr 6, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 6, 2021
Teas Change Of Correspondence Received
Apr 6, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 6, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 6, 2021
Teas Change Of Owner Address Received
Feb 27, 2021
Change Of Name/Address Rec'd From Ib
Nov 29, 2020
Refusal Processed By Ib
Nov 12, 2020
Non-Final Action Mailed - Refusal Sent To Ib
Nov 12, 2020
Refusal Processed By Mpu
Oct 23, 2020
Non-Final Action (Ib Refusal) Prepared For Review
Oct 22, 2020
Non-Final Action Written
Oct 19, 2020
Assigned To Examiner
Sep 22, 2020
Application Filing Receipt Mailed
Sep 18, 2020
New Application Office Supplied Data Entered
Sep 17, 2020
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
